Holdings

Propel Bio Management, LLC

As of Sep 30, 2026, Propel Bio Management, LLC reported 29 positions worth US$186M. Largest: Plains GP Holdings, L.P., Achieve Life Sciences, Inc. and Delcath Systems, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Plains GP Holdings, L.P.1.27MUS$33Mno changeSep 30, 2026
Achieve Life Sciences, Inc.3.86MUS$31.3M−170KSep 30, 2026
Delcath Systems, Inc.605KUS$9.66M−267KSep 30, 2026
Collegium Pharmaceutical, Inc.410KUS$8.95MnewSep 30, 2026
Corcept Therapeutics Incorporated75,274US$8.67M−61,225Sep 30, 2026
Aquestive Therapeutics, Inc.279KUS$8.61M−1.16MSep 30, 2026
Milestone Pharmaceuticals Inc.9.45MUS$8.18M+2.02MSep 30, 2026
Phathom Pharmaceuticals, Inc.1.11MUS$8.07M+55,555Sep 30, 2026
COMPASS Pathways Plc549KUS$6.83MnewSep 30, 2026
Orchestra BioMed Holdings, Inc.897KUS$5.58Mno changeSep 30, 2026